Smoking does not predispose higher response rate to Atezolizumab from IMvigor 210

Smoking does not predispose higher response rate to Atezolizumab from IMvigor 210

User Photo
AnnualMeeting2016

4 years
429 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Dr. Evan Yu, MD of University of Washington School of Medicine notes that smoking does not predispose higher response rate to Atezolizumab according to the IMvigor210 data. ASCO 2016
Up Next Autoplay
>